The shares of software name Palantir Technologies Inc (NYSE:PLTR) are up 1.6% to trade at $24.42 at last check. The equity has been trading mostly sideways since March, after cooling off from a Jan. 27, all-time high of $45, which is more than four times its initial public offering (IPO) price of $10. Shares regained support at the 10-day moving average in mid-May, and over the last month have added 24.4%.

Additionally, the security recently appeared on Schaeffer's Senior Quantitative Analyst Rocky White's list of stocks that have attracted the highest weekly options volume within the last two weeks. In Palantir Technologies stock's case,1,247,258 weekly calls and 296,645 weekly puts have crossed the tape during this time.

The brokerage bunch is pessimistic towards Palantir Technologies stock, with three of the four in question carrying a tepid "hold" or worse rating, while only one said "strong buy." Plus, the 12-month consensus target price of $22.43 is an 8.7% discount to the stock's current perch. This leaves ample room for price-target hikes and/or upgrades going forward, which could push shares higher. 

Lastly, the equity looks ripe for a short squeeze. Short interest is up 53.5% in the last two reporting periods, and the 85.27 million shares sold short make up 6.1% of PLTR's available float.

Clover Health Investments Corp (NASDAQ:CLOV) is enjoying a boost today, up 23.5% at $11.11 this afternoon, with many Reddit-based traders now targeting a fresh round of stocks with high volumes of short interest. The security is still trading well below its Jan. 4 record high of $17.45, and sports a 33% year-to-date deficit, though it's eyeing a close above its 200-day moving average for the first time since its formation in April. 

The surge has sparked a melee of activity in the options pits, with 340,000 calls and 29,000 puts exchanged so far -- eight times the intraday average. The most popular is the June 11 call, followed by the 10 call in the same monthly series, with positions being opened at the former. This suggests these traders expect CLOV to maintain some of today's price action up until these contracts expire on Friday, June 18. 

Calls have been quite popular lately. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), CLOV sports a 10-day call/put volume ratio of 14.06, and its Schaeffer's put/call open interest ratio (SOIR) stands at 0.21. 

This sentiment isn't reflected elsewhere, though. As we mentioned earlier, CLOV is heavily shorted at the moment, with short interest rising 7.7% in the last reporting period. The 40.46 million shares sold short make up a whopping 36.1% of the stock's available  float. 

Analyst sentiment, meanwhile, is lukewarm. Just one of the three covering CLOV call it a "strong buy," while two say "hold." Plus, the 12-month consensus price target of $9.67 is a 13.4% discount to current levels. 

RA Medical Systems Inc (NYSE:RMED) is shooting out of penny stock territory this morning, up 65.2% at $8.06 at last check, as the heavily shorted stock looks to be one of the latest victims of the "meme" stock craze. In fact, short interest on RMED is sitting at its highest volume on record, and the 1.06 million shares sold short make up a hefty 23.9% of the stock's available float. 

RMED's journey on the charts since going public back in 2018 has been dismal, with the stock initially traded well above the $510 level. The equity hit rock bottom on May 19, touching a record low of $2.85 -- quite a ways away from its 2018 levels. The 20-day moving average kept pressure on the stock during its most recent leg lower, though recent volatility has RMED once again distancing itself from the trendline. 

The stock is no stranger to wild price moves. A little under a month ago, RA Medical Systems stock saw an 18.1% post-earnings pop, though the 200-day moving average kept a lid on these gains. Should today's price action hold, RMED could be set to clear this trendline for the first time since February 2020, and notch its biggest one-day jump ever.